Pharmaceutical researchers and manufacturers are driven to develop new dosage forms that not only enhance drug delivery efficacy but also improve patient compliance and experience.
Today’s patients prioritise products that offer superior taste, texture, appearance and convenience, making consumer preferences a key driver for innovation. These innovative dosage forms are often small and complex, introducing substantial production and quality control challenges. Formulation and quality control processes must be exacting, demanding unprecedented accuracy beyond what traditional analysis methods can deliver.
Researchers and manufacturers must also adhere to stringent regulatory requirements, necessitating exceptionally accurate analysis with data that is recorded meticulously and impeccably for every single operation of drug research, development and production.
Download the whitepaper and case study: